Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countries

por Yoo, Hyun Kyeong, Byun, Han Geul, Caprioli, Flavio, Fumery, Mathurin, Peyrin-Biroulet, Laurent, Sreedhar, Subramanian, Potter, James, Jang, Minyoung
Publicado 2022